Teva Pharmaceutical Industries Ltd share price logo

Teva Pharmaceutical Industries Ltd Share Price

NYSE: TEVA

Large Cap

$29.32

-1.14

(-3.76%)

as on

Teva Pharmaceutical Industries Ltd Stock Performance

as on March 13, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $29.27
    $30.23
    downward going graph

    0.17%

    Downside

    3.10%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $12.47
    $37.35
    downward going graph

    57.49%

    Downside

    27.37%

    Upside

    downward going graph

Teva Pharmaceutical Industries Ltd share price movements today

Previous Close
$30.47
Open
$29.96
Volume
6.4M
Day's Low - High
$29.27 - $30.23
52 Week Low - High
$12.47 - $37.35

Teva Pharmaceutical Industries Ltd Historical Returns

1 Month Return
-13.77 %
3 Month Return
-1.64 %
1 Year Return
+ 78.01 %
3 Year Return
+ 227.74 %
5 Year Return
+ 171.55 %

Teva Pharmaceutical Industries Ltd Stock Fundamentals & Key Indicators

Check Teva Pharmaceutical Industries Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$35.5B

EPS (TTM)

2.6808

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.40%

PE Ratio (TTM)

25.18

Industry PE ratio

17.7675641025641

PEG Ratio

1.5166

EBITDA

5.0B

Revenue (TTM)

17.3B

Profit Margin

8.17%

Return On Equity TTM

20.79%

Teva Pharmaceutical Industries Ltd Stock Valuation

Track how Teva Pharmaceutical Industries Ltd P/E has moved over time to understand its valuation trends.

Teva Pharmaceutical Industries Ltd in the last 5 years

  • Overview

  • Trends

Lowest (3.34x)

March 31, 2022

Industry (17.77x)

March 13, 2026

Today (25.18x)

March 13, 2026

Highest (12.90x)

December 31, 2024

LowHigh

Today’s Price to Earnings Ratio: 25.18x

Teva Pharmaceutical Industries Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Teva Pharmaceutical Industries Ltd with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
SELL$35.5B171.55%25.188.17%
BUY$23.4BNA19.1541.94%
HOLD$16.1B-3.9%-21.95-24.58%
BUY$44.5BNA20.8315.11%
BUY$52.8B-24.32%2028.24%

Stock Returns calculator for Teva Pharmaceutical Industries Ltd Stock including INR - Dollar returns

The Teva Pharmaceutical Industries Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Teva Pharmaceutical Industries Ltd investment value today

Current value as on today

₹1,83,918

Returns

₹83,918

(+83.92%)

Returns from Teva Pharmaceutical Industries Ltd Stock

₹78,129 (+78.13%)

Dollar Returns*

₹5,789 (+5.79%)

Analyst Recommendation on Teva Pharmaceutical Industries Ltd Stock

Based on 9 analysts

SELL

0.00%

Buy

33.33%

Hold

66.67%

Sell

Based on 9 analysts, 66.67% of analysts recommend a 'SELL' rating for Teva Pharmaceutical Industries Ltd. Average target price of $38.14

Teva Pharmaceutical Industries Ltd Share Price Target

Get share price movements and forecasts by analysts on Teva Pharmaceutical Industries Ltd.

What analysts predicted

23.13%UPSIDE

Target Price

$38.14

Current Price

$29.32

Analyzed by

9 Analysts

Target

$38.14

Teva Pharmaceutical Industries Ltd target price $38.14, a slight upside of 23.13% compared to current price of $29.32. According to 9 analysts rating.

Teva Pharmaceutical Industries Ltd Stock’s Investor Sentiment and Interest

Search interest for Teva Pharmaceutical Industries Ltd Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Teva Pharmaceutical Industries Ltd Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
3,850
4,457
3,819
4,164
4,331
4,229
3,891
4,176
4,480
4,711
Gross Profit
1,851
2,416
1,771
2,024
2,148
2,120
1,877
2,102
2,304
2,656
Operating Income
344
756
-218
-5
-51
-29
519
455
882
300
EBITDA
627
1,517
55
246
207
1,162
763
657
1,104
632
Interest Expense
280
260
250
241
272
763
225
203
209
292
Depreciation
283
266
272
259
259
269
244
251
249
260
Income Before Tax
64
508
-471
-244
-321
-247
294
204
648
91
Income Tax Expense
-12
41
-52
630
69
28
74
-78
214
-390
Net Income
69
463
-139
-846
-437
-217
214
282
433
480
Net Profit Margin
1.79%
10.39%
-3.64%
-20.32%
-10.09%
-5.13%
5.50%
6.75%
9.67%
10.19%

Teva Pharmaceutical Industries Ltd Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
21,903
22,385
18,854
16,887
16,659
15,878
14,925
15,846
16,544
17,257
Gross Profit
11,859
10,825
8,296
7,536
7,726
7,594
6,973
7,645
8,063
8,938
Operating Income
2,154
-17,484
-1,637
-443
-3,572
1,716
-2,197
433
-303
2,157
EBITDA
2,866
-15,516
186
4,438
4,612
4,409
-925
433
4,431
3,141
Interest Expense
1,330
895
881
957
755
891
930
1,029
941
916
Depreciation
-
2,112
1,842
1,722
1,557
1,330
1,308
1,153
1,059
1,002
Income Before Tax
824
-18,379
-2,596
-723
-3,931
667
-3,142
-624
-1,283
1,238
Income Tax Expense
521
-1,933
-195
278
168
211
-643
-65
676
-180
Net Income
329
-16,265
-2,150
-999
-3,990
417
-2,446
-559
-1,639
1,410
Net Profit Margin
1.50%
-72.66%
-11.40%
-5.92%
-23.95%
2.63%
-16.39%
-3.53%
-9.91%
8.17%

Teva Pharmaceutical Industries Ltd Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
433
-419
-874
-390
-275
220
283
434
481
Operating Cash Flow
1,184
-124
103
693
575
-105
227
369
1,158
Investing Cash Flow
301
144
178
268
202
201
236
135
165
Financing Cash Flow
-576
-151
-966
-
-674
-1,744
6
-453
40
Change in Cash
977
-236
-733
1,061
-19
-1,603
464
42
1,353

Teva Pharmaceutical Industries Ltd Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16,449
-2,472
76
-4,099
456
-2,406
-615
-1,959
1,418
Operating Cash Flow
3,507
2,446
538
1,216
798
1,590
1,368
1,247
1,649
Investing Cash Flow
2,164
1,866
1,355
863
1,523
656
968
792
737
Financing Cash Flow
-5,750
-3,351
-241
-1,885
-2,172
-1,487
-1,913
-1,791
-2,151
Change in Cash
-25
819
734
202
21
636
393
73
256

Global Institutional Holdings in Teva Pharmaceutical Industries Ltd

Funds
Holdings
Geode Capital Management, LLC
0.86%
Morgan Stanley - Brokerage Accounts
0.56%
NORGES BANK
3.02%
WCM Investment Management
1.2%
State Street Corp
1.47%

Teva Pharmaceutical Industries Ltd News & Key Events

  • img

    Today's Timeline - 25 February

    Wed, 07:42 PM

    -

    Federal Circuit Court rules in favor of Teva, allowing marketing of generic Korlym.

    Wed, 08:10 PM

    -

    Teva Pharmaceutical Industries Ltd. holds a Zacks Rank of #2 (Buy) with improving earnings estimates.

Insights on Teva Pharmaceutical Industries Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Teva Pharmaceutical Industries Ltd has shown consistent improvement in its net profit over the last 7 quarters. The net profit has increased from a loss of $846.0 million to a profit of $480.0 million. This represents an average quarterly increase of 77.5%, indicating a strong upward trend in the company's profitability.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Teva Pharmaceutical Industries Ltd has shown positive revenue growth over the last four quarters, with revenues increasing from $3.89 billion to $4.71 billion. This represents an average increase of 6.2% in revenue each quarter.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 6 months, TEVA stock has moved up by 47.0%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, TEVA has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, TEVA has outperformed top 5 stocks with highest market-cap in its industry

About Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
OrganisationTeva Pharmaceutical Industries Ltd
Headquarters124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020
IndustryHealth Technology
CEOMr. Richard D. Francis
E-voting on sharesClick here to vote

Key Management of Teva Pharmaceutical Industries Ltd

Name

Title

Dr. Eric A. Hughes M.D., Ph.D.

Executive VP of Global R&D and Chief Medical Officer

Mr. Matthew Shields

Executive Vice President of Global Operations

Mr. Christopher J. Stevo CFA

Senior Vice President of Investor Relations & Competitive Intelligence

Kathleen Veit

Senior Vice President, Global Compliance & Ethics Officer

Mr. Placid Jover

Executive VP & CHRO

Mr. Richard D. Francis

President, CEO & Director

Mr. Richard Gordon Daniell

Executive Vice President of European Commercial

Ms. Christine Fox

Executive VP of US Commercial & Head of Innovative Franchise

Mr. Amir Weiss

Senior VP & Chief Accounting Officer

Mr. Eliyahu Sharon Kalif

Executive VP & CFO

FAQs

What is Teva Pharmaceutical Industries Ltd share price today?

Teva Pharmaceutical Industries Ltd share price today is $29.32 as on at the close of the market. Teva Pharmaceutical Industries Ltd share today touched a day high of $30.23 and a low of $29.27.

What is the 52 week high and 52 week low for Teva Pharmaceutical Industries Ltd share?

Teva Pharmaceutical Industries Ltd share touched a 52 week high of $37.35 on and a 52 week low of $12.47 on . Teva Pharmaceutical Industries Ltd stock price today i.e. is closed at $29.32,which is 21.49% down from its 52 week high and 135.22% up from its 52 week low.

What is Teva Pharmaceutical Industries Ltd's market capitalisation today?

Teva Pharmaceutical Industries Ltd market capitalisation is $0.04T as on .

How to invest in Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Teva Pharmaceutical Industries Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Teva Pharmaceutical Industries Ltd Shares that will get you 0.0512 shares as per Teva Pharmaceutical Industries Ltd share price of $29.32 per share as on March 13, 2026 at 1:29 am IST.

What is the minimum amount required to buy Teva Pharmaceutical Industries Ltd Stock (TEVA) from India?

Indian investors can start investing in Teva Pharmaceutical Industries Ltd (TEVA) shares with as little as ₹92.206 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹922.06 in Teva Pharmaceutical Industries Ltd stock (as per the Rupee-Dollar exchange rate as on ). Based on Teva Pharmaceutical Industries Ltd share’s latest price of $29.32 as on March 13, 2026 at 1:29 am IST, you will get 0.3411 shares of Teva Pharmaceutical Industries Ltd. Learn more about fractional shares .

What are the returns that Teva Pharmaceutical Industries Ltd has given to Indian investors in the last 5 years?

Teva Pharmaceutical Industries Ltd stock has given 171.55% share price returns and 26.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?